Cardiora Overview

  • Founded
  • 2015
Founded
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

Cardiora General Information

Description

Developer of an oral drug designed to prevent heart failure. The company's oral drug is a compound that has functional outcomes with ensured safety, enabling patients to avail improved quality of life and reduced hospital re-admission rates.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • Level 9, 31 Queen Street
  • Melbourne, Victoria 3000
  • Australia
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cardiora Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 02-Apr-2021 00.000 Completed Out of Business
1. Early Stage VC (Series A) 23-Nov-2015 00.000 00.000 Completed Pre-Clinical Trials
To view Cardiora’s complete valuation and funding history, request access »